<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01775722</url>
  </required_header>
  <id_info>
    <org_study_id>NIH/LAMMP-2012-9092</org_study_id>
    <nct_id>NCT01775722</nct_id>
  </id_info>
  <brief_title>Combined Bipolar Radiofrequency&amp;Pulsed Dye Laser Treatment</brief_title>
  <official_title>Combined Bipolar Radiofrequency and Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Candela Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beckman Laser Institute University of California Irvine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Port wine stain Birthmark is a congenital, progressive vascular malformation of human skin.
      However, even though the pulsed dye laser is considered as the treatment of choice for Port
      wine stain Birthmark the degree of fading can remain variable and unpredictable after laser
      treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The researcher want to use the combination of radiofrequency electrical energy with pulsed
      dye laser light energy which can improve therapeutic outcome of Port wine stain Birthmark.
      This investigational device is essentially a combination of two commercially available
      systems cleared for marketing (K044351 and K052324) provided by Candela Laser Corporation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent Change in Blanching of Port Wine Stain</measure>
    <time_frame>8 weeks</time_frame>
    <description>Port Wine Stain blood volume fractions in the skin before (fB1), and 8 weeks after (fB2) treatment will be determined using the corresponding visual reflectance spectra measured at the treatment sites. The primary outcome, degree of blanching, B, is computed as B = (fB1-fB2)/fB1.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Port-Wine Stain</condition>
  <arm_group>
    <arm_group_label>Pulsed Dye Laser</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>port wine stain treatment using Pulse Dye Laser</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bipolar Radiofrequency&amp;Pulsed Dye Laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Port wine stain using Combined Bipolar Radiofrequency&amp;Pulsed Dye Laser</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pulsed Dye Laser</intervention_name>
    <description>port wine stain</description>
    <arm_group_label>Pulsed Dye Laser</arm_group_label>
    <other_name>candela-Laser</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Combined Bipolar Radiofrequency&amp;Pulsed Dye Laser</intervention_name>
    <description>Combined Bipolar Radiofrequency&amp;Pulsed Dye Laser Treatment</description>
    <arm_group_label>Bipolar Radiofrequency&amp;Pulsed Dye Laser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Port Wine Stain suitable for comparison testing

          2. Age &gt; 12 years of age; minor will be accompanied in the room by parents or guardians
             during laser treatment

          3. Apparent good health as documented by medical history

          4. Ability to understand and carry out subject instructions

        Exclusion Criteria:

          1. History of photodermatoses or skin cancer

          2. Any therapy within the previous two months to the proposed port wine stain treatment
             sites

          3. Current participation in any other investigational drug or device evaluation

          4. Concurrent use of known photosensitizing drugs

          5. Inability to understand and carry out instructions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J. Stuart Nelson, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beckman Laser Institute, UCI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beckman Laser Institute Medical Clinic</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 14, 2013</study_first_submitted>
  <study_first_submitted_qc>January 22, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 25, 2013</study_first_posted>
  <results_first_submitted>August 27, 2015</results_first_submitted>
  <results_first_submitted_qc>March 9, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">April 9, 2018</results_first_posted>
  <last_update_submitted>March 9, 2018</last_update_submitted>
  <last_update_submitted_qc>March 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Irvine</investigator_affiliation>
    <investigator_full_name>Beckman Laser Institute and Medical Center</investigator_full_name>
    <investigator_title>J.S.Nelson, MD,PhD,Professor of Surgery and Biomedical Engineering</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Port-Wine Stain</mesh_term>
    <mesh_term>Hemangioma, Capillary</mesh_term>
    <mesh_term>Vascular Malformations</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Combined Radio Frequency and Pulsed Dye Laser Treatment</title>
          <description>This is a within-participant design due to the response of port wine stain to laser therapy varies greatly from patient to patient. Pulsed dye laser only test site and combined radio frequency and pulsed dye laser test site were placed side by side on each subjectâ€™s port wine stain area. Thus the differences among subjects will be explicitly accounted for and removed from the error component when assessing treatment effects.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Combined Radio Frequency and Pulsed Dye Laser Treatment</title>
          <description>There are two test sites on each Port Wine Stain, one test site was treated with Pulsed dye laser only, and another test site was treated with combined radio frequency and pulsed dye laser. Two test sites were placed side by side randomly on each subjectâ€™s port wine stain area.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Combined Bipolar Radiofrequency&amp;Pulsed Dye Laser Treatment</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percent Change in Blanching of Port Wine Stain</title>
        <description>Port Wine Stain blood volume fractions in the skin before (fB1), and 8 weeks after (fB2) treatment will be determined using the corresponding visual reflectance spectra measured at the treatment sites. The primary outcome, degree of blanching, B, is computed as B = (fB1â€“fB2)/fB1.</description>
        <time_frame>8 weeks</time_frame>
        <population>Each subject received both treatments on their corresponding test sites. We compared response of test sites to different treatment.</population>
        <group_list>
          <group group_id="O1">
            <title>Pulsed Dye Laser Only Treatment</title>
            <description>Measurement on the test site treated with Pulsed Dye Laser only.</description>
          </group>
          <group group_id="O2">
            <title>Combined Radio Frequency and Pulsed Dye Laser Treatment</title>
            <description>Measurement on test sites treated with combined Radio Frequency and Pulsed Dye Laser.</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Change in Blanching of Port Wine Stain</title>
          <description>Port Wine Stain blood volume fractions in the skin before (fB1), and 8 weeks after (fB2) treatment will be determined using the corresponding visual reflectance spectra measured at the treatment sites. The primary outcome, degree of blanching, B, is computed as B = (fB1â€“fB2)/fB1.</description>
          <population>Each subject received both treatments on their corresponding test sites. We compared response of test sites to different treatment.</population>
          <units>percentage</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Test site</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Test site</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" spread="8"/>
                    <measurement group_id="O2" value="5" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>8 weeks</time_frame>
      <desc>No adverse event reported</desc>
      <group_list>
        <group group_id="E1">
          <title>Pulsed Dye Laser Only Treatment</title>
          <description>Adverse event on the test site treated with Pulsed Dye Laser only.</description>
        </group>
        <group group_id="E2">
          <title>Combined Radio Frequency and Pulsed Dye Laser Treatment</title>
          <description>Adverse event on test sites treated with combined Radio Frequency and Pulsed Dye Laser.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>J Stuart Nelson</name_or_title>
      <organization>University of California, Irvine. Beckamn Laser Institute</organization>
      <phone>9498247997</phone>
      <email>jsnelson@uci.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

